1. Home
  2. NFLX vs NVS Comparison

NFLX vs NVS Comparison

Compare NFLX & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Netflix Inc.

NFLX

Netflix Inc.

N/A

Current Price

$79.42

Market Cap

308.7B

ML Signal

N/A

Logo Novartis AG

NVS

Novartis AG

N/A

Current Price

$155.42

Market Cap

293.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NFLX
NVS
Founded
1997
1895
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
308.7B
293.9B
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
NFLX
NVS
Price
$79.42
$155.42
Analyst Decision
Strong Buy
Hold
Analyst Count
34
5
Target Price
$119.23
$144.00
AVG Volume (30 Days)
28.5M
1.4M
Earning Date
04-16-2026
04-28-2026
Dividend Yield
N/A
2.16%
EPS Growth
N/A
N/A
EPS
2.03
N/A
Revenue
$45,183,036,000.00
N/A
Revenue This Year
$15.99
$2.30
Revenue Next Year
$11.74
$5.27
P/E Ratio
$40.10
$23.13
Revenue Growth
15.85
N/A
52 Week Low
$65.08
$121.57
52 Week High
$1,267.10
$170.46

Technical Indicators

Market Signals
Indicator
NFLX
NVS
Relative Strength Index (RSI) 62.43 49.48
Support Level $79.23 $149.30
Resistance Level $84.66 $160.13
Average True Range (ATR) 1.99 2.26
MACD 0.56 0.20
Stochastic Oscillator 82.39 52.99

Price Performance

Historical Comparison
NFLX
NVS

About NFLX Netflix Inc.

Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: